mesalamine has been researched along with Epidermolysis Bullosa Acquisita in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Epidermolysis Bullosa Acquisita: Form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. Direct immunofluorescence shows IMMUNOGLOBULIN G deposited at the dermo-epidermal junction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinowitz, BN | 1 |
| Towery, DS | 1 |
| Meyers, SW | 1 |
| Durick, WJ | 1 |
| Taira, JW | 1 |
1 other study available for mesalamine and Epidermolysis Bullosa Acquisita
| Article | Year |
|---|---|
Successful treatment of epidermolysis bullosa acquisita with mesalazine.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Epidermolysis Bullosa Acquisita; Fema | 1997 |